BF.B
59
-2
CMCSA
42
8
DOW
43
-5
CHRW
73
-4
SEE
56
3
CFG
93
-2
UNH
38
2
CPB
39
2
EW
50
-3
AVGO
38
-25
PRGO
36
-3
NI
63
-4
SLB
49
-4
CCI
42
-2
TRIP
57
-4
CNX
52
-8
KR
32
2
AAP
12
-14
DRI
53
-3
AA
67
-5
BF.B
59
-2
CMCSA
42
8
DOW
43
-5
CHRW
73
-4
SEE
56
3
CFG
93
-2
UNH
38
2
CPB
39
2
EW
50
-3
AVGO
38
-25
PRGO
36
-3
NI
63
-4
SLB
49
-4
CCI
42
-2
TRIP
57
-4
CNX
52
-8
KR
32
2
AAP
12
-14
DRI
53
-3
AA
67
-5
Financhill
Back

Solitario Resources Corp. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Buy
54

XPL
Solitario Resources Corp.

Last Price:
$0.67
Seasonality Move:
15.88%
Sell
48

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$36.24
Seasonality Move:
6.21%
Buy
54
Solitario Resources Corp. (XPL) is a Buy

Is Solitario Resources Corp. a Buy, Sell or Hold?

  • The current Solitario Resources Corp. [XPL] share price is $0.67. The Score for XPL is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • XPL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $36.23. The Score for RARE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XPL Stock Price Chart

What is Solitario Resources Corp.'s stock price today?

  • The Solitario Resources Corp. share price today is $0.67
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XPL is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $36.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.

XPL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.11 Buy
Relative Strength Index (14 RSI): 57.67 Buy
Chaikin Money Flow: -19103 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.58 - 0.64) Buy
Bollinger Bands (100): (0.63 - 0.77) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.99 Buy
Relative Strength Index (14 RSI): 61.17 Buy
Chaikin Money Flow: -31475 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.18 - 35.78) Buy
Bollinger Bands (100): (28.77 - 33.95) Buy

XPL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.64 Buy
20-day SMA: 0.61 Buy
50-day SMA: 0.66 Buy
200-day SMA: 0.67 Buy
8-day EMA: 0.64 Buy
20-day EMA: 0.57 Buy
50-day EMA: 0.37 Buy
200-day EMA: 0.13 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.32 Sell
20-day SMA: 34.36 Buy
50-day SMA: 33.41 Buy
200-day SMA: 33.75 Buy
8-day EMA: 35.88 Buy
20-day EMA: 34.85 Buy
50-day EMA: 33.54 Buy
200-day EMA: 34.8 Buy

Solitario Resources Corp. Earnings Growth & XPL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.05 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Solitario Resources Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):